All Infection Prevention & Control articles – Page 5
-
News‘FluWarning’ system raises early alerts for virus spillovers
How can we monitor the cross-species transmission of avian flu? The answer is FluWarning, a digital system that reports abnormal changes in flu viruses. It analyses their genetic code, looking for subtle but significant changes that could indicate cross-species transmission.
-
NewsNew vaccine against a deadly virus acts fast and protects for over a year
A research team has developed a vaccine made from a non-infectious version of the Crimean-Congo hemorrhagic fever virus that protects quickly and provides long-lasting immunity.
-
NewsNew flu strain underscores urgent need for vigilance, vaccination, and investment in virus science
Virologists have issued a statement on the emergence of a new influenza A (H3N2) variant known as H3N2 subclade K that is spreading rapidly and may contribute to a more intense flu season worldwide. Public health agencies have reported sharp week-over-week increases in cases driven by this subclade.
-
NewsScientists uncover how COVID-19 variants outsmart the immune system
Researchers have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes COVID-19, and how viral mutations weaken that attachment.
-
NewsGlobal Virus Network awards pandemic preparedness grants to advance global surveillance and early detection of viral threats
The Global Virus Network (GVN) is awarding pandemic preparedness research grants, totaling $160,000, to scientists across four continents, supporting innovative, investigator-led projects designed to enhance viral surveillance, early detection, and scientific preparedness.
-
NewsNew research confirms HPV vaccination prevents cervical cancer
Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.
-
NewsRebalancing lung repair with immune damage is key to surviving severe influenza
Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to a new study in mice, which shows that pairing modest antiviral therapies with immune modulation can restore damaged tissues and lung function, even after severe infection has taken hold.
-
NewsMaternal health programme cuts infection deaths by 32%
A landmark multi-country clinical trial has shown that a structured, sustainable approach to infection prevention and treatment can save women’s lives, cutting severe maternal infections and deaths by about one-third (32%) compared to usual care.
-
NewsResearchers diagnose disease with a drop of blood, a microscope and AI
Scientists have developed an automated, high-throughput system that relies on imaging droplets of biofluids for disease diagnosis in an attempt to reduce the number of consumables and equipment needed for biomedical testing.
-
NewsScientists use computer model to improve hospitals’ ability to limit spread of drug-resistant infections
The computer model improves on traditional methods like contact tracing by inferring asymptomatic carriers in the spread of antibiotic-resistant infections.
-
NewsSmart toilet designs in Cambodia held promise, but a key piece was missing
A smart toilet design introduced in rural Cambodia was supposed to change lives—keeping families safe and protecting the environment. However, while households reported that they liked the new system, a crucial piece was missing: using it correctly.
-
NewsStudy unveils structure, identification and characterization of the RibD-enolase complex in Francisella
A study aiming to identify anti-tularemia drug targets determined the atomic structure and identified its components of the native RibD-enolase protein complex in Francisella novicida.
-
NewsNew nanogel technology destroys drug-resistant bacteria in hours
A novel technology shows over 99.9% effectiveness against Pseudomonas aeruginosa (P. aeruginosa). It centres on a heteromultivalent nanogel: a flexible particle made by crosslinking polymers and adding sugar residues (galactose and fucose) alongside antimicrobial peptides.
-
NewsGSK and Fleming Initiative scientists unite to target AMR with advanced AI
GSK and the Fleming Initiative have announced six major new research programmes, called ‘Grand Challenges’ which harness some of the best scientific expertise and the latest technologies, including advanced AI, to find new ways to slow the progress of antimicrobial resistance (AMR).
-
NewsScripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
Scripps Research scientists will purchase high-performance computing equipment to accelerate the identification of more effective HIV vaccine candidates through enhanced computational infrastructure, reduced data-processing bottlenecks, and state-of-the-art artificial intelligence (AI) technology.
-
News$3.7 million awarded for research into sand flies, vectors of parasitic disease leishmaniasis
Professor Gideon Wasserberg at UNC Greensboro has been awarded a prestigious $3.7 million National Institutes of Health R01 grant to advance his research on controlling sand flies, the vectors of the parasitic disease leishmaniasis.
-
NewsResearchers expand virus-based treatment options for antibiotic-resistant infections
Phages are extremely specific about which strains of a bacterial species they will attack. This has limited their effectiveness against the most antibiotic-resistant strains. To overcome this problem, the research team “trained” the phages by allowing them to evolve together with the bacteria in a controlled laboratory setting for 30 days.
-
NewsPhase 2 clinical trial results show potential to shorten TB treatment time
New clinical trial results show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the potential to improve tuberculosis (TB) treatment when combined with pretomanid and linezolid in a treatment regimen known as “SPaL.”
-
NewsDid US cities’ indoor vaccine mandates affect COVID-19 vaccination rates and outcomes?
New research reveals that despite widespread adoption of indoor vaccine mandates in major US cities during the COVID-19 pandemic, there is no consistent evidence that these policies significantly increased vaccination rates or reduced COVID-19–related outcomes. The findings contrast with those from other countries, as national mandates abroad boosted vaccine uptake.
-
NewsApriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.